IV Equipment Market

The global IV equipment market is projected to reach USD 23.92 billion by 2031 from USD 17.82 billion in 2026, growing at a CAGR of 6.1% during the forecast period.

The IV equipment market is growing rapidly due to increasing hospitalizations, a rise in chronic and lifestyle-related diseases, and greater use of IV therapy for medications, hydration, and nutrition. Aging populations, more surgeries, and improved healthcare access worldwide are driving higher demand. Additionally, innovations in safer, more efficient IV devices are encouraging hospitals and clinics to adopt advanced equipment, further fueling market growth.

To know about the assumptions considered for the study download the pdf brochure

• In April 2025, the US FDA cleared the BD Alaris Infusion System with Guardrails Suite MX (including modules like PC Unit, Pump, Syringe, PCA, EtCO2, Auto-ID, and System Manager) as safe & effective for market use. This clearance, granted on April 25, 2025, confirms that the system is substantially equivalent to previously approved devices and can now be legally sold in the US.
• In March 2024, B. Braun entered into a collaboration with Orlando Health to co-develop new solutions that improve access to care for both patients and clinicians. The partnership focuses on addressing challenges in the evolving pharmacy and infusion therapy landscape.

Prominent players in this market include Becton, Dickinson and Company (US), B. Braun SE (Germany), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (US), Terumo Corporation (Japan), Moog Inc. (US), Teleflex Incorporated (US), Cardinal Health (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Baxter (US), Avanos Medical, Inc. (US), Nipro (Japan), JMS Co., Ltd. (Japan), Vygon (France), and Micrel Medical Devices SA (Greece).

BECTON, DICKINSON AND COMPANY (US)

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. BD develops & manufactures products across 190 countries. The major subsidiaries of the company include Staged Diabetes Management LLC (US), Becton Dickinson Venezuela, C.A. (Venezuela), Nippon Becton Dickinson Company, Ltd. (Japan), Becton Dickinson U.K. Ltd. (UK), and Becton, Dickinson A.G. (Switzerland).

BAXTER (US)

Baxter International Inc. develops, manufactures, and markets medical devices, pharmaceuticals, and biotechnology products for a wide range of acute & chronic diseases. The company provides a broad portfolio of essential healthcare products, including acute & chronic dialysis therapies, sterile IV solutions, infusion systems & devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostats & sealants. The company has a global presence, with 50 manufacturing sites in 20 countries and sales networks in 100 countries. Its leading subsidiaries include Baxter Healthcare Corporation (US), Baxter Sales and Distribution LLC (US), Baxter Corporation (Canada), Baxter Oncology GmbH (Germany), Baxter S.p.A. (Italy), and Baxter AG (Switzerland).

B. BRAUN SE (GERMANY)

B. Braun SE is a leading healthcare supplier that provides products for applications in anesthesia, intensive care, cardiology, extracorporeal blood treatment, and surgery. The Hospital Care segment provides infusion therapy injection systems and clinical nutrition products for inpatient care. B. Braun is present in about 64 countries across North America, Europe, the Asia Pacific, Africa, the Middle East, and Latin America. It has 299 consolidated companies worldwide. Its subsidiaries include B. Braun Surgical GmbH (Germany), B. Braun Medical A/S (Denmark), B. Braun Medical B.V. (Netherlands), B. Braun Medical S.A. (Spain), and B. Braun Aesculap Japan Co. Ltd. (Japan).

Market Ranking

The IV equipment market is highly consolidated, with major players such as Becton, Dickinson and Company (US), Baxter (US), and B. Braun SE (Germany) holding the largest market shares. These leading companies have strong global networks and well-established distribution channels in regions like North America and Europe. They leverage partnerships, advanced research and development, and brand strength to maintain their competitive edge. In contrast, smaller companies compete by offering low-cost products and innovative technologies, creating a market landscape that features a mix of dominant global firms and agile, competitive regional providers.

Related Reports:

IV Equipment Market by Type (IV Catheter, IV Administration Set, Needle-free Connectors), Application (Medication Administration, Parenteral Nutrition, Diagnostic Testing, Blood & Blood Product Transfusion), End User (Hospital) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com